Bruno Osterwalder
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- HER2/EGFR in Cancer Research
- Dermatology top 0.5%
- Chemotherapy-related skin toxicity
Papers in
- Hematology 24
- Hematopoietic Stem Cell Transplantation 16
- Blood groups and transfusion 3
- Oncology 28
- Colorectal Cancer Treatments and Studies 15
- Cancer Treatment and Pharmacology 12
- Co-authors
- Tom Griffin (5 shared papers)Aman U. Buzdar (2 shared papers)Paulo M. Hoff (3 shared papers)Hans Ulrich Burger (3 shared papers)Chris J. Twelves (8 shared papers)Stephen E. Jones (2 shared papers)Jean Alfred Maroun (2 shared papers)Walter Kocha (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (5 papers)British Journal of Cancer (5 papers)European Journal of Cancer (4 papers)Annals of Hematology (3 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Bruno Osterwalder
64 papers receiving 5.7k citations
Bruno Osterwalder's Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 4.2k
- Dermatology 619
- Hematology 554
- Hepatology 301
- Cancer Research 541
Countries citing papers authored by Bruno Osterwalder
This map shows the geographic impact of Bruno Osterwalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Osterwalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Osterwalder more than expected).
Fields of papers citing papers by Bruno Osterwalder
This network shows the impact of papers produced by Bruno Osterwalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Osterwalder. The network helps show where Bruno Osterwalder may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Osterwalder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study Hit paper breakdown → | 2001 | 954 |
| 2 | Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study Hit paper breakdown → | 2001 | 882 |
| 3 | Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer Hit paper breakdown → | 1999 | 709 |
| 4 | 2002 | 442 | |
| 5 | 2001 | 359 | |
| 6 | 2001 | 281 | |
| 7 | 2000 | 274 | |
| 8 | 1998 | 235 | |
| 9 | 1998 | 226 | |
| 10 | 2002 | 165 | |
| 11 | Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. | 1998 | 141 |
| 12 | 2001 | 140 | |
| 13 | 2002 | 122 | |
| 14 | 1981 | 119 | |
| 15 | 1983 | 106 | |
| 16 | 1994 | 96 | |
| 17 | 2000 | 87 | |
| 18 | Treatment of severe aplastic anemia. | 1986 | 83 |
| 19 | A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. | 1998 | 77 |
| 20 | 1985 | 69 |
About Bruno Osterwalder
Bruno Osterwalder is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Genetics and Dermatology, having authored 66 papers that have together received 6.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (12 papers), Transplantation: Methods and Outcomes (4 papers), Chemotherapy-related skin toxicity (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Mesenchymal stem cell research (4 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Oncology (4.2k citations), Dermatology (619 citations), Hematology (554 citations), Hepatology (301 citations) and Cancer Research (541 citations). Bruno Osterwalder has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Tom Griffin, Aman U. Buzdar, Paulo M. Hoff, Hans Ulrich Burger, Chris J. Twelves, Stephen E. Jones, Jean Alfred Maroun, Walter Kocha, Bruno G. Reigner and Joanne Lorraine Blum. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.